David A. Metcalfe - 01 Dec 2022 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Role: Chief Technology Officer
Signature: /s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Issuer symbol: N/A
Transactions as of: 01 Dec 2022
Net transactions value: -$381,133
Form type: 4
Filing time: 02 Dec 2022, 16:05:12 UTC
Previous filing: 04 Nov 2022
Next filing: 28 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXGN	Common Stock	Options Exercise	$285,002	+20,256	+12%	$14.07	193,551	01 Dec 2022	Direct	F1
transaction	NXGN	Common Stock	Sale	$666,135	-32,372	-17%	$20.58	161,179	01 Dec 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXGN	Stock Option (right to buy)	Options Exercise	$0	-20,256	-19%	$0.000000	87,234	01 Dec 2022	Common Stock	20,256	$14.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.48 to $20.87. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
F3	Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.